Table 1.
Expression (i. e. staining intensity) of CREB and HLA-G in ccRCC with respect to primary tumor WHO grade
| ccRCC | WHO grade 1 n (%) | WHO grade 2 n (%) |
WHO grade 3 n (%) |
|---|---|---|---|
| CREB | |||
| Negative (0) | 0 (0.0) | 24 (50.0) | 24 (50.0) |
| Weak (1) | 10 (11.5) | 58 (66.7) | 19 (21.8) |
| Moderate (2) | 17 (15.9) | 75 (70.1) | 15 (14.0) |
| Strong (3) | 15 (21.1) | 46 (64.8) | 10 (14.1) |
| Cytoplasmic HLA-G | |||
| Negative (0) | 40 (19.9) | 126 (62.7) | 35 (17.4) |
| Weak (1) | 6 (9.8) | 40 (65.6) | 15 (24.6) |
| Moderate (2) | 2 (3.7) | 38 (70.4) | 14 (25.9) |
| Strong (3) | 2 (12.5) | 7 (43.8) | 7 (43.8) |
| Membranous HLA-G | |||
| Negative (0) | 20 (13.6) | 95 (64.6) | 32 (21.8) |
| Weak (1) | 12 (18.8) | 45 (70.3) | 7 (10.9) |
| Moderate (2) | 11 (18.0) | 35 (57.4) | 15 (24.6)) |
| Strong (3) | 7 (11.7) | 36 (60.0) | 17 (28.3) |